These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16723230)

  • 1. Rippling muscle disease.
    Roberts HL; Day B; Lo H; McLean C; North K
    J Clin Neurosci; 2006 Jun; 13(5):576-8. PubMed ID: 16723230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel missense mutation in the caveolin-3 gene in rippling muscle disease.
    Lorenzoni PJ; Scola RH; Vieira N; Vainzof M; Carsten AL; Werneck LC
    Muscle Nerve; 2007 Aug; 36(2):258-60. PubMed ID: 17405141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new missense mutation in caveolin-3 gene causes rippling muscle disease.
    Dotti MT; Malandrini A; Gambelli S; Salvadori C; De Stefano N; Federico A
    J Neurol Sci; 2006 Apr; 243(1-2):61-4. PubMed ID: 16458928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thought ripples on muscle waves: recognition of rippling muscle disease.
    Voermans NC; van Alfen N; Drost G; Ginjaar HB; Willemsen MA
    Neuropediatrics; 2008 Apr; 39(2):116-8. PubMed ID: 18671188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset toe walking in rippling muscle disease due to a new caveolin-3 gene mutation.
    Madrid RE; Kubisch C; Hays AP
    Neurology; 2005 Oct; 65(8):1301-3. PubMed ID: 16247063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rippling muscle disease: variable phenotype in a family with five afflicted members.
    Jacobi C; Ruscheweyh R; Vorgerd M; Weber MA; Storch-Hagenlocher B; Meinck HM
    Muscle Nerve; 2010 Jan; 41(1):128-32. PubMed ID: 19697367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel homozygous mutation of the caveolin-3 gene in rippling muscle disease with extraocular muscle paresis.
    Ueyama H; Horinouchi H; Obayashi K; Hashinaga M; Okazaki T; Kumamoto T
    Neuromuscul Disord; 2007 Jul; 17(7):558-61. PubMed ID: 17537631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene.
    Catteruccia M; Sanna T; Santorelli FM; Tessa A; Di Giacopo R; Sauchelli D; Verbo A; Lo Monaco M; Servidei S
    Neuromuscul Disord; 2009 Nov; 19(11):779-83. PubMed ID: 19773168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers.
    Sundblom J; Stålberg E; Osterdahl M; Rücker F; Montelius M; Kalimo H; Nennesmo I; Islander G; Smits A; Dahl N; Melberg A
    Muscle Nerve; 2010 Jun; 41(6):751-7. PubMed ID: 20229577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rippling muscle disease in children].
    Zhang WH; Zou LP
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):156-8. PubMed ID: 15833181
    [No Abstract]   [Full Text] [Related]  

  • 11. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
    Gazzerro E; Bonetto A; Minetti C
    Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin 3 deficiency myopathy associated with dyslipidemia: Treatment challenges and possible pathophysiological association.
    Ibarretxe D; Pellejà J; Ortiz N; Masana L
    J Clin Lipidol; 2017; 11(5):1280-1283. PubMed ID: 28807458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal recessive rippling muscle disease with homozygous CAV3 mutations.
    Kubisch C; Ketelsen UP; Goebel I; Omran H
    Ann Neurol; 2005 Feb; 57(2):303-4. PubMed ID: 15668980
    [No Abstract]   [Full Text] [Related]  

  • 14. Teaching Video NeuroImages: Rippling muscle disease with caveolin myopathy.
    Bourque PR; Breiner A; Brooks J; Warman Chardon J
    Neurology; 2018 Oct; 91(18):e1726-e1727. PubMed ID: 30373930
    [No Abstract]   [Full Text] [Related]  

  • 15. Rippling muscle disease in childhood.
    Schara U; Vorgerd M; Popovic N; Schoser BG; Ricker K; Mortier W
    J Child Neurol; 2002 Jul; 17(7):483-90. PubMed ID: 12269726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.
    Schoser B; Jacob S; Hilton-Jones D; Müller-Felber W; Kubisch C; Claus D; Goebel HH; Vita G; Vincent A; Toscano A; Van den Bergh P
    Neuromuscul Disord; 2009 Mar; 19(3):223-8. PubMed ID: 19208478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncation of Caveolin-3 causes autosomal-recessive Rippling Muscle Disease.
    Traverso M; Bruno C; Broccolini A; Sotgia F; Donati MA; Assereto S; Gazzerro E; Lo Monaco M; Modoni A; D'Amico A; Gasperini S; Ricci E; Zara F; Lisanti M; Minetti C
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):735-7. PubMed ID: 18487559
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy.
    Müller JS; Piko H; Schoser BG; Schlotter-Weigel B; Reilich P; Gürster S; Born C; Karcagi V; Pongratz D; Lochmüller H; Walter MC
    Neuromuscul Disord; 2006 Jul; 16(7):432-6. PubMed ID: 16730439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolinopathies: from the biology of caveolin-3 to human diseases.
    Gazzerro E; Sotgia F; Bruno C; Lisanti MP; Minetti C
    Eur J Hum Genet; 2010 Feb; 18(2):137-45. PubMed ID: 19584897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrically active immune-mediated rippling muscle disease preceding breast cancer.
    Liewluck T; Goodman BP; Milone M
    Neurologist; 2012 May; 18(3):155-8. PubMed ID: 22549359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.